A comprehensive view of Laboratory Corp. of America Holdings (LabCorp). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Labcorp and Quest Diagnostics expand portfolios with new blood tests for neurodegenerative disorders; Labcorp's test tracks molecules released after neurological damage, Quest introduces Alzheimer's protein test pTau-217 to its AD-Detect line
Published:
April 22, 2024
by FierceBiotech
|
Labcorp completes acquisition of Baystate Health’s outreach laboratory business and select operating assets; Labcorp aiming to enhance affordable, high-quality healthcare services for Massachusetts' underserved communities
Published:
April 22, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp introduces first commercial GFAP blood biomarker test in US that offers an efficient way to assess neurodegenerative diseases and neurological injuries; test can be conducted in hospitals, physician's offices or any of Labcorp's service centers
Published:
April 15, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp Declares Quarterly Dividend
Published:
April 11, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp Publishes 2023 Corporate Responsibility Report
Published:
April 10, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Ask us about our Health Care Sector market view